Skip to Content

Workers’ Compensation Board

Search menu

Subject Number 046-1161 Temporary Suspension of Dr. Thomas A. Ranieri

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 157792-3W

April 23, 2019

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Thomas A. Ranieri’s authorization to treat injured workers within the New York State workers’ compensation system effective April 19, 2019. Dr. Ranieri's last known business address is:

321 W Camino Real
Boca Raton, Florida 33432-5705

The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Commissioner’s Order of Summary Action # 19-075, prohibiting Dr. Ranieri from practicing medicine in the State of New York, or in any setting under the authority of his New York license, pending the outcome of a hearing conducted before the State Board for Professional Medical Conduct. This limitation is based on a Pennsylvania Board Order, pursuant to which Dr. Ranieri’s Pennsylvania license was temporarily suspended in connection with a Federal Grand Jury Indictment returned against him on December 13, 2017 alleging Distribution of Schedule II controlled substances outside the usual course of professional practice.

Therefore, the Chair believes that Dr. Ranieri may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Ranieri is prohibited from rendering treatment and care to injured workers and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a) while his authorization is temporarily suspended. Reports submitted by Dr. Ranieri for services rendered prior to April 19, 2019 are valid but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Ranieri for services rendered prior to April 19, 2019 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Clarissa M. Rodriguez
Chair